A 24-Week, Multi-Center, Open-Label Evaluation Of Compliance And Tolerability Of The Once-Daily 10 Cm Exelon Patch Formulation In Patients With Probable Alzheimer'S Disease

| Funding period: 2008 - 2009

Completed

Researchers